Clearstead Advisors, LLC Treace Medical Concepts, Inc. Transaction History
Clearstead Advisors, LLC
- $7.4 Billion
- Q3 2025
A detailed history of Clearstead Advisors, LLC transactions in Treace Medical Concepts, Inc. stock. As of the latest transaction made, Clearstead Advisors, LLC holds 83 shares of TMCI stock, worth $251. This represents 0.0% of its overall portfolio holdings.
Number of Shares
83
Previous 10
730.0%
Holding current value
$251
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding TMCI
# of Institutions
122Shares Held
58.3MCall Options Held
0Put Options Held
0-
Cibc Bancorp Usa Inc. Chicago, IL18.2MShares$55.2 Million0.15% of portfolio
-
Armistice Capital, LLC New York, NY6.32MShares$19.1 Million0.65% of portfolio
-
Black Rock Inc. New York, NY4.07MShares$12.3 Million0.0% of portfolio
-
William Blair Investment Management, LLC Chicago, IL3.63MShares$11 Million0.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.73MShares$8.28 Million0.0% of portfolio
About TREACE MEDICAL CONCEPTS, INC.
- Ticker TMCI
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 55,403,300
- Market Cap $168M
- Description
- Treace Medical Concepts, Inc., an orthopedic medical device company, engages in the design, manufacture, and marketing of medical devices for foot and ankle surgeons in the United States. It offers Lapiplasty procedure that allows podiatric surgeons to treat all three dimensions of the bunion, providing patients with a cosmetic and medical impro...